Indivior Accused Of Overstating Prospects Of 3 Opioid Drugs

By Katryna Perera · August 5, 2024, 8:29 PM EDT

Drugmaker Indivior PLC has been hit with a proposed investor class action in Virginia federal court over claims it overstated the financial prospects of its drugs used to treat opioid use disorders...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login